Company name: Echo Pharmaceuticals
Description: Provider and supplier of active pharmaceutical ingredients intended to improve the quality of life for a wide range of patients. The company offers cannabinoid-based medicines and drug delivery technologies.
Year founded: 2006
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company is in talks to acquire Samco Gold (TSXV: SGA) through a reverse merger, resulting in the combined entity trading on the Toronto Stock Exchange under the ticker symbol ECHO on April 17, 2019.
Number of active investors:
Profile last updated:
Last known valuation:
Last known valuation date: